Background There are a lot of Oxidative stress reports on the tumorigenesis and development in the breast,thyroid,colorectal cancer and lung cancer,but most of them are about one or several kinds of oxidant/antioxidan...
详细信息
Background There are a lot of Oxidative stress reports on the tumorigenesis and development in the breast,thyroid,colorectal cancer and lung cancer,but most of them are about one or several kinds of oxidant/antioxidant markers,lack of total oxidant *** purpose of this experiment is to detect total oxidation state(TOS),total antioxidant status(TAS)and oxidative stress index(OSI)in lung cancer patients and healthy person *** explore the relationship between oxidative stress status with lung cancer.
Cachexia is one of the most common complications in patients with malignant *** occurrence and development of cancer cachexia can be found and prevented at early stage,so prevention should be given as soon as we can t...
详细信息
Cachexia is one of the most common complications in patients with malignant *** occurrence and development of cancer cachexia can be found and prevented at early stage,so prevention should be given as soon as we can to a patient who was diagnosed with a malignant *** should take multi-level and individualized measures according to the development of tumor and nutritional status,as well as the characteristics of different cachexia *** also needs four-dimensional prevention strategy,that is,Pharmaceuticals-Exercise-Nutrition-Psychotherapy(PENP).With the development of precise medical science,we should use metabonomics method to explore the molecular markers of the occurrence and development of cachexia,to predict the risk of cachexia,and to provide the basis for the early prevention of cachexia.
Obiective:To observe the efficacy and toxicities of combined nimotuzumab with chemoradiotherapy as the first line treatment to advanced esophageal squamous cell carcinoma(ESCC).Methods:The clinical data of 43 patients...
详细信息
Obiective:To observe the efficacy and toxicities of combined nimotuzumab with chemoradiotherapy as the first line treatment to advanced esophageal squamous cell carcinoma(ESCC).Methods:The clinical data of 43 patients with local advanced or metastatic esophageal squamous cell carcinoma treated with nimotuzumab combined with chemoradiotherapy in our hospital were included in this retrospective *** overall response,treatment toxicities,overall survival(OS)and progressive free survival(PFS)were analyzed with SPSS software.
Aims:To evaluate the prognostic value of a new clinical staging system for esophageal cancer to predict survival after(chemo)***:This retrospective study enrolled 444 patients with esophageal squamous cell carcinoma w...
详细信息
Aims:To evaluate the prognostic value of a new clinical staging system for esophageal cancer to predict survival after(chemo)***:This retrospective study enrolled 444 patients with esophageal squamous cell carcinoma who underwent definitive intensity-modulated radiotherapy with or without chemotherapy between January 2008 and May 2014.A clinical staging system based on the gross tumor volume and maximum diameter of metastatic lymph nodes was developed and the prognostic value of this staging system was compared with that of the 8th edition of American Joint Committee on Cancer TNM staging system.
暂无评论